BRAIN Biotech (Group)

https://www.brain-biotech.com

BRAIN Biotech AG (“BRAIN”) is a leading European industrial biotechnology specialist with a focus on nutrition, health and the environment. As a technology and solutions provider the company supports the biologization of industries with bio-based products and processes. From contract R&D with industrial partners to advancing own disruptive incubator projects and customized enzyme products – BRAIN’s broad cutting-edge biotech expertise and its agile teams are key to success. BRAIN Biotech AG, Germany, is the parent company of the international BRAIN Group, distributing specialty B2B products like enzymes or bioactive natural products. The BRAIN Group has its own fermentation or production facilities in Continental Europe, UK and the US, which together with the associated biotechnological solution competency complete the value chain within the group. As a Participant of the United Nations Global Compact, BRAIN Biotech AG is committed to aligning strategies and operations with universal principles on human rights, labour, environment and anti-corruption and to actively advance common societal goals. Our products and services target at least five of the UN SDGs directly. Since its IPO in 2016, BRAIN Biotech AG is listed in the Prime Standard of the Frankfurt Stock Exchange (ISIN DE0005203947 / WKN 520394). *

	Start	1993-01-01 established
	End	renamed
	Industry	BIOTECH
	Industry 2	WHITE BIOTECHNOLOGY
	Person	Moelker, Adriaan (BRAIN 202002– CEO before Flint Group + AB Enzymes + Genencor + DSM)
	Person 2	Linnig, Lukas (Akribion Therapeutics 202502 Co-CEO + Co-Founder before BRAIN Biotech)

	Region	Zwingenberg
	Country	Germany
	Street	34-36 Darmstädter Str.
	City	64673 Zwingenberg
	Tel	06251-9331-0
		Address record changed: 2021-05-13

Basic data	Employees	D: 101 to 500 (2022-09-30)
	Currency	EUR
	Annual sales	49,509,000 (revenues, consolidated (2021/22) 2022-09-30)
	Profit	-6,341,000 (2022-09-30)
	Cash	8,443,000 (2022-09-30)

		* Document for »About Section«: BRAIN Biotech AG. (5/30/22). "Press Release: Prof. Dr. Bernhard Hauer Leaves Supervisory Board of BRAIN Biotech AG for personal reasons". Zwingenberg.

		Record changed: 2025-03-16